| mRNA |
paclitaxel |
UHNBreast |
pan-cancer |
AAC |
-0.41 |
0.2 |
| mRNA |
lapatinib |
UHNBreast |
pan-cancer |
AAC |
-0.2 |
0.5 |
| mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
2e-05 |
| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
6e-05 |
| mRNA |
myriocin |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.08 |
| mRNA |
BRD-K30748066 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.3 |
| mRNA |
GDC-0941 |
gCSI |
pan-cancer |
AAC |
-0.13 |
0.02 |
| mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0006 |
| mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.001 |
| mRNA |
Crizotinib |
gCSI |
pan-cancer |
AAC |
-0.11 |
0.04 |